LU92232I2 - "Florbétapir (18 F)" - Google Patents

"Florbétapir (18 F)"

Info

Publication number: LU92232I2
Authority: LU; Luxembourg
Prior art keywords: compounds; amyloid deposits; methods; relates; making
Prior art date: 2006-03-30

Application number

LU92232C

Other languages

English (en)

Other versions

LU92232I9 (fr

Original Assignee

Trustees Of The University Of Pennsylvania Ct For Technology Transfer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-30

Filing date

2013-06-26

Publication date

2013-08-26

2013-06-26 Application filed by Trustees Of The University Of Pennsylvania Ct For Technology Transfer filed Critical Trustees Of The University Of Pennsylvania Ct For Technology Transfer

2013-08-26 Publication of LU92232I2 publication Critical patent/LU92232I2/fr

2019-01-15 Publication of LU92232I9 publication Critical patent/LU92232I9/fr

Links

208000037259 Amyloid Plaque Diseases 0.000 abstract 4
238000000034 method Methods 0.000 abstract 4
BIAWAXVRXKIUQB-UHFFFAOYSA-N 2-(2-phenylethenyl)pyridine Chemical class C=1C=CC=CC=1C=CC1=CC=CC=N1 BIAWAXVRXKIUQB-UHFFFAOYSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
238000003384 imaging method Methods 0.000 abstract 2
102000009091 Amyloidogenic Proteins Human genes 0.000 abstract 1
108010048112 Amyloidogenic Proteins Proteins 0.000 abstract 1
238000004220 aggregation Methods 0.000 abstract 1
230000002776 aggregation Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Optics & Photonics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Neurology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

LU92232C 2006-03-30 2013-06-26 "Florbétapir (18 F)" LU92232I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US78715606P	2006-03-30	2006-03-30

Publications (2)

Publication Number	Publication Date
LU92232I2 true LU92232I2 (fr)	2013-08-26
LU92232I9 LU92232I9 (fr)	2019-01-15

Family

ID=38326579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU92232C LU92232I2 (fr)	2006-03-30	2013-06-26	"Florbétapir (18 F)"

Country Status (34)

Country	Link
US (3)	US7687052B2 (fr)
EP (3)	EP2363391A1 (fr)
JP (1)	JP5290954B2 (fr)
KR (1)	KR101376807B1 (fr)
CN (1)	CN101522624B (fr)
AT (1)	ATE539060T1 (fr)
AU (1)	AU2007243712B2 (fr)
BR (1)	BRPI0710225B1 (fr)
CA (1)	CA2644530C (fr)
CR (1)	CR10329A (fr)
CY (3)	CY1113048T1 (fr)
DK (2)	DK2363392T3 (fr)
EA (1)	EA017898B1 (fr)
EC (1)	ECSP088783A (fr)
ES (2)	ES2378785T3 (fr)
FR (1)	FR13C0034I2 (fr)
GT (1)	GT200800201A (fr)
HR (2)	HRP20120135T1 (fr)
HU (2)	HUE032660T2 (fr)
IL (1)	IL193567A (fr)
LT (1)	LT2363392T (fr)
LU (1)	LU92232I2 (fr)
MX (1)	MX2008012527A (fr)
NO (2)	NO342090B1 (fr)
NZ (1)	NZ570887A (fr)
PL (2)	PL1999109T3 (fr)
PT (2)	PT2363392T (fr)
RS (2)	RS56171B1 (fr)
SG (1)	SG173338A1 (fr)
SI (2)	SI2363392T1 (fr)
TW (1)	TWI399366B (fr)
UA (1)	UA97802C2 (fr)
WO (1)	WO2007126733A2 (fr)
ZA (1)	ZA200807955B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA97802C2 (uk)	2006-03-30	2012-03-26	Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания	Стирилпіридинові похідні і їх застосування для зв'язування і візуалізації амілоїдних бляшок
WO2009004914A1 (fr) *	2007-07-04	2009-01-08	Tohoku University	Sonde de tep ayant un groupe alcoxy substitué par un atome de fluor et un groupe hydroxy
US8557222B2 (en) *	2008-04-04	2013-10-15	Avid Radiopharmaceuticals, Inc.	Radiopharmaceutical imaging of neurodegenerative diseases
CN102271716B (zh) *	2008-12-31	2014-11-19	阿维德放射性药品公司	由甲苯磺酸酯前体合成18f-放射性标记的苯乙烯基吡啶及其稳定的药物组合物
US8968701B2 (en) *	2009-07-10	2015-03-03	Piramal Imaging Sa	Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
WO2011045415A2 (fr)	2009-10-15	2011-04-21	Guerbet	Nouveaux agents d'imagerie et leur utilisation pour le diagnostic in vivo de maladies neurodégénératives, notamment la maladie d'alzheimer et les maladies dérivées
BR112012015369A2 (pt) *	2009-12-23	2018-01-23	Piramal Imaging Sa	formulacões adequadas para realização de imagens de pet com agentes pet hidrofóbicos
WO2011141515A1 (fr)	2010-05-14	2011-11-17	Bayer Pharma Aktiengesellschaft	Agents de diagnostic pour l'imagerie d'amyloïdes bêta
MX2012014115A (es)	2010-06-04	2013-07-03	Piramal Imaging Sa	Metodo para la produccion de ligandos beta amiloide marcados con 18f.
TWI504414B (zh)	2010-06-04	2015-10-21	Bayer Schering Pharma Ag	生產Ｆ－１８標記之Ａβ配位體之方法
US20130209363A1 (en)	2010-06-04	2013-08-15	Piramal Imaging Sa	Method for production of f-18 labeled amyloid beta ligands
AU2011260419A1 (en) *	2010-06-04	2012-12-20	Piramal Imaging Sa	Method for production of F-18 labeled amyloid beta ligands
CN101891674B (zh) *	2010-06-24	2012-11-14	山东大学	4-苯乙烯基吡啶类化合物及其制备方法与应用
US9259495B2 (en) *	2010-10-12	2016-02-16	Mayo Foundation For Medical Education And Research	Imaging of meningiomas using phenylbenzothiazole, stilbene, or biphenylalkyne derivatives
US20140079635A1 (en) *	2011-03-30	2014-03-20	Case Western Reserve University	Molecular probes for detecting lipid composition
WO2012145169A2 (fr)	2011-04-21	2012-10-26	The Regents Of The University Of California	Nanoparticules magnétiques fonctionnalisées et leur utilisation dans l'imagerie de dépôts amyloïdes et d'enchevêtrements neurofibrillaires
JP2015501305A (ja)	2011-10-19	2015-01-15	ピラマルイメージングソシエテアノニム	Ｆ‐１８標識Ａβリガンドの改良された製造方法
PT2836241T (pt)	2012-04-10	2019-05-30	Lantheus Medical Imaging Inc	Métodos de síntese de radiofármacos
JP6099045B2 (ja) *	2013-04-30	2017-03-22	国立大学法人京都大学	トリアゾロピリミジン誘導体化合物
JP6041751B2 (ja) *	2013-05-07	2016-12-14	日本メジフィジックス株式会社	スチリルピリジン誘導体化合物
JP2014218454A (ja) *	2013-05-07	2014-11-20	日本メジフィジックス株式会社	スチリルピリジン誘導体化合物
CN103645254B (zh) *	2013-11-28	2015-01-07	江苏省原子医学研究所	一种Aβ斑块显像剂前体AV45的含量分析方法
MX384604B (es) *	2014-05-13	2025-03-14	Hoffmann La Roche	Compuestos heterocíclicos deuterados y su uso como agentes formadores de imágenes.
US10478513B2 (en)	2015-08-18	2019-11-19	The Regents Of The University Of Califonia	Nitroxide containing amyloid binding agents for imaging and therapeutic uses
US10300155B2 (en)	2015-12-31	2019-05-28	Washington University	Alpha-synuclein ligands
CN109400615B (zh) *	2017-08-18	2021-07-16	上海交通大学医学院附属新华医院	一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
CN108299287A (zh) *	2018-01-02	2018-07-20	北京师范大学	与Aβ斑块具有高亲和力的N2S2类吡啶基苯乙烯化合物
CN114805190A (zh) *	2022-06-08	2022-07-29	吉林大学第一医院	一种甲基苯胺类Aβ蛋白显像剂的双柱合成方法
EP4619384A1 (fr)	2022-11-14	2025-09-24	Eli Lilly and Company	Formes polymorphes de précurseur av-105 de florbétapir

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992000963A1 (fr) *	1990-07-12	1992-01-23	Yoshitomi Pharmaceutical Industries, Ltd.	Composes de styryle et leur utilisation comme medicaments
JPH0545875A (ja) *	1991-08-08	1993-02-26	Konica Corp	感光性組成物
US6020436A (en) *	1993-03-09	2000-02-01	The Chromaline Corporation	Photosensitive resin composition
TW544448B (en) *	1997-07-11	2003-08-01	Novartis Ag	Pyridine derivatives
US20030138374A1 (en) *	2000-03-22	2003-07-24	Yukitsuda Kudo	Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
US8007954B2 (en)	2000-11-09	2011-08-30	The Trustees Of The University Of Pennsylvania	Use of sulfur-containing fuels for direct oxidation fuel cells
JP2002182254A (ja)	2000-12-18	2002-06-26	Fuji Photo Film Co Ltd	非線形光学材料とその製造方法
AU2002323417B2 (en) *	2001-08-27	2008-05-15	The Trustees Of The University Of Pennsylvania	Stilbene derivatives and their use for binding and imaging amyloid plaques
WO2003105252A2 (fr)	2002-06-06	2003-12-18	The Trustees Of The University Of Pennsylvania	Anodes de ceramique et procede de production de ces anodes
WO2004016271A1 (fr) *	2002-08-14	2004-02-26	Axxima Pharmaceuticals Ag	Pyrimidones en tant qu'agents antiviraux
JP4482352B2 (ja)	2004-03-11	2010-06-16	本田技研工業株式会社	固体高分子型燃料電池
US7807135B2 (en) *	2004-12-17	2010-10-05	The Trustees Of The University Of Pennsylvania	Stilbene derivatives and their use for binding and imaging amyloid plaques
US7858072B2 (en) *	2004-12-17	2010-12-28	The Trustees Of The University Of Pennsylvania	Stilbene derivatives and their use for binding and imaging amyloid plaques
US20070031328A1 (en) *	2005-06-24	2007-02-08	Kung Hank F	Radiolabeled-pegylation of ligands for use as imaging agents
UA97802C2 (uk) *	2006-03-30	2012-03-26	Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания	Стирилпіридинові похідні і їх застосування для зв'язування і візуалізації амілоїдних бляшок
US20080253967A1 (en) *	2007-04-13	2008-10-16	Kung Hank F	Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques

2007
- 2007-03-26 UA UAA200812698A patent/UA97802C2/uk unknown
- 2007-03-26 DK DK11152124.1T patent/DK2363392T3/en active
- 2007-03-26 ES ES07753982T patent/ES2378785T3/es active Active
- 2007-03-26 SI SI200731938T patent/SI2363392T1/sl unknown
- 2007-03-26 AT AT07753982T patent/ATE539060T1/de active
- 2007-03-26 HU HUE11152124A patent/HUE032660T2/en unknown
- 2007-03-26 RS RS20170578A patent/RS56171B1/sr unknown
- 2007-03-26 US US11/727,401 patent/US7687052B2/en active Active
- 2007-03-26 EA EA200870389A patent/EA017898B1/ru not_active IP Right Cessation
- 2007-03-26 SG SG2011048477A patent/SG173338A1/en unknown
- 2007-03-26 HR HR20120135T patent/HRP20120135T1/hr unknown
- 2007-03-26 PT PT111521241T patent/PT2363392T/pt unknown
- 2007-03-26 EP EP11152115A patent/EP2363391A1/fr not_active Withdrawn
- 2007-03-26 SI SI200730865T patent/SI1999109T1/sl unknown
- 2007-03-26 MX MX2008012527A patent/MX2008012527A/es active IP Right Grant
- 2007-03-26 BR BRPI0710225-9A patent/BRPI0710225B1/pt active IP Right Grant
- 2007-03-26 PL PL07753982T patent/PL1999109T3/pl unknown
- 2007-03-26 DK DK07753982.3T patent/DK1999109T3/da active
- 2007-03-26 CA CA2644530A patent/CA2644530C/fr active Active
- 2007-03-26 JP JP2009502912A patent/JP5290954B2/ja active Active
- 2007-03-26 EP EP11152124.1A patent/EP2363392B1/fr active Active
- 2007-03-26 AU AU2007243712A patent/AU2007243712B2/en active Active
- 2007-03-26 PT PT07753982T patent/PT1999109E/pt unknown
- 2007-03-26 EP EP07753982A patent/EP1999109B1/fr active Active
- 2007-03-26 RS RS20120077A patent/RS52222B/sr unknown
- 2007-03-26 CN CN2007800116909A patent/CN101522624B/zh active Active
- 2007-03-26 WO PCT/US2007/007400 patent/WO2007126733A2/fr not_active Ceased
- 2007-03-26 PL PL11152124T patent/PL2363392T3/pl unknown
- 2007-03-26 ES ES11152124.1T patent/ES2628882T3/es active Active
- 2007-03-26 NZ NZ570887A patent/NZ570887A/en unknown
- 2007-03-26 LT LTEP11152124.1T patent/LT2363392T/lt unknown
- 2007-04-26 TW TW096114833A patent/TWI399366B/zh active
2008
- 2008-08-05 US US12/186,072 patent/US8506929B2/en active Active
- 2008-08-20 IL IL193567A patent/IL193567A/en active IP Right Grant
- 2008-09-16 ZA ZA2008/07955A patent/ZA200807955B/en unknown
- 2008-09-29 KR KR1020087023884A patent/KR101376807B1/ko active Active
- 2008-09-30 GT GT200800201A patent/GT200800201A/es unknown
- 2008-09-30 EC EC2008008783A patent/ECSP088783A/es unknown
- 2008-09-30 CR CR10329A patent/CR10329A/es unknown
- 2008-10-29 NO NO20084590A patent/NO342090B1/no active Protection Beyond IP Right Term
2012
- 2012-03-07 CY CY20121100225T patent/CY1113048T1/el unknown
2013
- 2013-01-07 US US13/735,609 patent/US8840866B2/en active Active
- 2013-06-26 LU LU92232C patent/LU92232I2/fr unknown
- 2013-06-26 FR FR13C0034C patent/FR13C0034I2/fr active Active
- 2013-06-27 HU HUS1300028C patent/HUS1300028I1/hu unknown
- 2013-06-27 CY CY2013024C patent/CY2013024I2/el unknown
2017
- 2017-06-06 HR HRP20170857TT patent/HRP20170857T1/hr unknown
- 2017-06-22 CY CY20171100664T patent/CY1119048T1/el unknown
2018
- 2018-09-11 NO NO2018030C patent/NO2018030I1/no unknown

Also Published As

Publication number	Publication date
US20080038195A1 (en)	2008-02-14
EP1999109B1 (fr)	2011-12-28
EA200870389A1 (ru)	2009-04-28
LU92232I9 (fr)	2019-01-15
DK2363392T3 (en)	2017-07-03
ES2628882T3 (es)	2017-08-04
CA2644530A1 (fr)	2007-11-08
US8840866B2 (en)	2014-09-23
CY2013024I1 (el)	2015-11-04
TW200838852A (en)	2008-10-01
JP5290954B2 (ja)	2013-09-18
UA97802C2 (uk)	2012-03-26
FR13C0034I1 (fr)	2013-08-09
HUS1300028I1 (hu)	2017-08-28
KR20080106564A (ko)	2008-12-08
EP2363392A1 (fr)	2011-09-07
SG173338A1 (en)	2011-08-29
EP2363391A1 (fr)	2011-09-07
CY1113048T1 (el)	2015-11-04
PL1999109T3 (pl)	2012-05-31
PT2363392T (pt)	2017-06-15
GT200800201A (es)	2009-08-20
HRP20170857T1 (hr)	2017-12-01
FR13C0034I2 (fr)	2014-03-07
CY2013024I2 (el)	2015-11-04
CA2644530C (fr)	2015-05-19
BRPI0710225A2 (pt)	2011-08-02
NO342090B1 (no)	2018-03-19
US8506929B2 (en)	2013-08-13
NO2018030I1 (no)	2018-09-11
PT1999109E (pt)	2012-03-16
SI1999109T1 (sl)	2012-04-30
RS56171B1 (sr)	2017-11-30
MX2008012527A (es)	2008-10-14
CN101522624B (zh)	2013-11-06
CY1119048T1 (el)	2018-01-10
IL193567A (en)	2014-03-31
SI2363392T1 (sl)	2017-09-29
ZA200807955B (en)	2012-11-28
EP1999109A2 (fr)	2008-12-10
TWI399366B (zh)	2013-06-21
IL193567A0 (en)	2009-05-04
CR10329A (es)	2008-10-29
AU2007243712A1 (en)	2007-11-08
US20090123369A1 (en)	2009-05-14
ES2378785T3 (es)	2012-04-17
AU2007243712B2 (en)	2013-01-10
CN101522624A (zh)	2009-09-02
HRP20120135T1 (hr)	2012-03-31
ECSP088783A (es)	2008-10-31
RS52222B (sr)	2012-10-31
WO2007126733A2 (fr)	2007-11-08
DK1999109T3 (da)	2012-04-02
WO2007126733A3 (fr)	2008-03-06
HUE032660T2 (en)	2017-10-30
JP2009532349A (ja)	2009-09-10
US20130129624A1 (en)	2013-05-23
NZ570887A (en)	2011-05-27
US7687052B2 (en)	2010-03-30
EA017898B1 (ru)	2013-04-30
EP2363392B1 (fr)	2017-05-03
PL2363392T3 (pl)	2017-10-31
KR101376807B1 (ko)	2014-03-20
NO20084590L (no)	2008-12-29
BRPI0710225B1 (pt)	2021-07-13
ATE539060T1 (de)	2012-01-15
LT2363392T (lt)	2017-07-25

Publication	Publication Date	Title
LU92232I2 (fr)	2013-08-26	"Florbétapir (18 F)"
MX2007007380A (es)	2007-10-11	Derivados de estilbeno y su uso para estudios de union y por imagenes de placas amiloides.
ATE349446T1 (de)	2007-01-15	Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
MY153198A (en)	2015-01-29	Inhibitors of protein aggregation
NO20076687L (no)	2007-12-28	Oral doseringsform
EP1933714A4 (fr)	2010-10-20	Systemes, compositions et procedes pour representer localement et traiter la douleur
EA201100062A1 (ru)	2011-08-30	Соединения и способы модулирования рецепторов, связанных с белком g
MX2009006075A (es)	2009-06-30	Derivados de acetileno y su uso para la union a placas amiloides y su diagnostico por imagenes.
WO2007033080A3 (fr)	2009-04-23	Agents d'imagerie pour la maladie d'alzheimer
WO2006078384A3 (fr)	2007-03-01	Derives de stilbene et leur utilisation pour fixer et imager des plaques amyloides
DK1553985T3 (da)	2011-12-12	Biphenyler som billeddannelsesmiddel i forbindelse med Alzheimers sygdom
WO2007016352A3 (fr)	2007-05-24	Compositions orales liquides de losartan
DK1847524T3 (da)	2010-01-11	Terphenylderivater til behandling af Alzheimers sygdom
ATE461693T1 (de)	2010-04-15	Verfahren zur behandlung von akuten rhinosinusitis
WO2008050133A3 (fr)	2008-06-19	Inhibition d'une agrégation de beta-amyloïde
IL185653A0 (en)	2008-01-06	Pharmaceutical compositions containing an antibody which binds the stalk region of kim-1
WO2010135493A3 (fr)	2011-04-21	Agents d'imagerie utilisés pour la maladie d'alzheimer
UA91996C2 (ru)	2010-09-27	Производные стильбена и их применение для связывания и визуализации амилоидных бляшек
ITBO20060237A1 (it)	2006-07-04	Metodo e macchina per l'incarto di articoli.
EP2021020A4 (fr)	2010-09-15	Protéines corégulées sécrétées par campylobacter flagella en tant qu'immunogènes
ITGE20050053A1 (it)	2007-01-09	Metodo di guida assistita per treni e apparato per l'attuazione di tale metodo.
FR2908997B1 (fr)	2014-03-14	Nouvelles compositions therapeutiques et le procede de production des principes actifs
ITMO20050086A1 (it)	2006-10-09	'dispositivo antifumo per sigarette o simili.'